BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36159811)

  • 21. A 2-Gene Signature Related to Interferon-Gamma Predicts Prognosis and Responsiveness to Immune Checkpoint Blockade of Glioma.
    Li Y; Ji H; Gao X
    Front Med (Lausanne); 2022; 9():846847. PubMed ID: 35492352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of CECR1 in M2-like TAMs promotes paracrine stimulation-mediated glial tumor progression.
    Zhu C; Mustafa D; Zheng PP; van der Weiden M; Sacchetti A; Brandt M; Chrifi I; Tempel D; Leenen PJM; Duncker DJ; Cheng C; Kros JM
    Neuro Oncol; 2017 May; 19(5):648-659. PubMed ID: 28453746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-cell RNA sequencing reveals changes in glioma-associated macrophage polarization and cellular states of malignant gliomas with high AQP4 expression.
    Wang R; Peng L; Xiao Y; Zhou Q; Wang Z; Tang L; Xiao H; Yang K; Liu H; Li L
    Cancer Gene Ther; 2023 May; 30(5):716-726. PubMed ID: 36599974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of a nine-gene signature in glioma patients based on tumor-associated macrophages expression profiling.
    Shan X; Zhang C; Wang Z; Wang K; Wang J; Qiu X; Jiang T; Yang P
    Clin Immunol; 2020 Jul; 216():108430. PubMed ID: 32325251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differentiated glioblastoma cells accelerate tumor progression by shaping the tumor microenvironment via CCN1-mediated macrophage infiltration.
    Uneda A; Kurozumi K; Fujimura A; Fujii K; Ishida J; Shimazu Y; Otani Y; Tomita Y; Hattori Y; Matsumoto Y; Tsuboi N; Makino K; Hirano S; Kamiya A; Date I
    Acta Neuropathol Commun; 2021 Feb; 9(1):29. PubMed ID: 33618763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-associated macrophage interleukin-β promotes glycerol-3-phosphate dehydrogenase activation, glycolysis and tumorigenesis in glioma cells.
    Lu J; Xu Z; Duan H; Ji H; Zhen Z; Li B; Wang H; Tang H; Zhou J; Guo T; Wu B; Wang D; Liu Y; Niu Y; Zhang R
    Cancer Sci; 2020 Jun; 111(6):1979-1990. PubMed ID: 32259365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interrogating glioma-M2 macrophage interactions identifies Gal-9/Tim-3 as a viable target against
    Ni X; Wu W; Sun X; Ma J; Yu Z; He X; Cheng J; Xu P; Liu H; Shang T; Xi S; Wang J; Zhang J; Chen Z
    Sci Adv; 2022 Jul; 8(27):eabl5165. PubMed ID: 35857445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy.
    Teng C; Zhu Y; Li Y; Dai L; Pan Z; Wanggou S; Li X
    Front Immunol; 2022; 13():899710. PubMed ID: 35677036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-expression modules of NF1, PTEN and sprouty enable distinction of adult diffuse gliomas according to pathway activities of receptor tyrosine kinases.
    Zhang W; Lv Y; Xue Y; Wu C; Yao K; Zhang C; Jin Q; Huang R; Li J; Sun Y; Su X; Jiang T; Fan X
    Oncotarget; 2016 Sep; 7(37):59098-59114. PubMed ID: 27385209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular profiling of the tumor microenvironment in glioblastoma patients: correlation of microglia/macrophage polarization state with metalloprotease expression profiles and survival.
    Gjorgjevski M; Hannen R; Carl B; Li Y; Landmann E; Buchholz M; Bartsch JW; Nimsky C
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31142630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas.
    Komohara Y; Ohnishi K; Kuratsu J; Takeya M
    J Pathol; 2008 Sep; 216(1):15-24. PubMed ID: 18553315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrative Analysis of DNA Methylation and Transcriptome Identifies a Predictive Epigenetic Signature Associated With Immune Infiltration in Gliomas.
    Zhang J; Yin J; Luo L; Huang D; Zhai D; Wang G; Xu N; Yang M; Song Y; Zheng G; Zhang Q
    Front Cell Dev Biol; 2021; 9():670854. PubMed ID: 34136486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour-associated microglia/macrophages predict poor prognosis in high-grade gliomas and correlate with an aggressive tumour subtype.
    Sørensen MD; Dahlrot RH; Boldt HB; Hansen S; Kristensen BW
    Neuropathol Appl Neurobiol; 2018 Feb; 44(2):185-206. PubMed ID: 28767130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA damage repair alterations modulate M2 polarization of microglia to remodel the tumor microenvironment via the p53-mediated MDK expression in glioma.
    Meng X; Duan C; Pang H; Chen Q; Han B; Zha C; Dinislam M; Wu P; Li Z; Zhao S; Wang R; Lin L; Jiang C; Cai J
    EBioMedicine; 2019 Mar; 41():185-199. PubMed ID: 30773478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. scRNA-seq and proteomics reveal the distinction of M2-like macrophages between primary and recurrent malignant glioma and its critical role in the recurrence.
    You G; Zheng Z; Huang Y; Liu G; Luo W; Huang J; Zhuo L; Tang B; Liu S; Lin C
    CNS Neurosci Ther; 2023 Nov; 29(11):3391-3405. PubMed ID: 37194413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Transcriptional Signature of PDGF-DD Activated Natural Killer Cells Predicts More Favorable Prognosis in Low-Grade Glioma.
    Sun Y; Sedgwick AJ; Palarasah Y; Mangiola S; Barrow AD
    Front Immunol; 2021; 12():668391. PubMed ID: 34539622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophage Ablation Reduces M2-Like Populations and Jeopardizes Tumor Growth in a MAFIA-Based Glioma Model.
    Gabrusiewicz K; Hossain MB; Cortes-Santiago N; Fan X; Kaminska B; Marini FC; Fueyo J; Gomez-Manzano C
    Neoplasia; 2015 Apr; 17(4):374-84. PubMed ID: 25925380
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Yu M; Chang Y; Zhai Y; Pang B; Wang P; Li G; Jiang T; Zeng F
    Front Immunol; 2022; 13():1089266. PubMed ID: 36713360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Gene Expression Signature in Patients With Distinct Glioma Grades.
    Ait Ssi S; Chraa D; El Azhary K; Sahraoui S; Olive D; Badou A
    Front Immunol; 2021; 12():685213. PubMed ID: 34539626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic transcriptome profiling of pyroptosis related signature for predicting prognosis and immune landscape in lower grade glioma.
    Yu H; Gong M; Qi J; Zhao C; Niu W; Sun S; Li S; Hong B; Qian J; Wang H; Chen X; Fang Z
    BMC Cancer; 2022 Aug; 22(1):885. PubMed ID: 35964070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.